Cargando…
Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a rare bile duct disease strongly associated with inflammatory bowel disease (IBD). Whole‐exome sequencing (WES) has contributed to understanding the molecular basis of very early‐onset IBD, but rare protein‐altering genetic variants hav...
Autores principales: | Haisma, Sjoukje‐Marije, Weersma, Rinse K., Joosse, Maria E., de Koning, Barbara A. E., de Meij, Tim, Koot, Bart G. P., Wolters, Victorien, Norbruis, Obbe, Daly, Mark J., Stevens, Christine, Xavier, Ramnik J., Koskela, Jukka, Rivas, Manuel A., Visschedijk, Marijn C., Verkade, Henkjan J., Barbieri, Ruggero, Jansen, Dianne B. H., Festen, Eleonora A. M., van Rheenen, Patrick F., van Diemen, Cleo C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252477/ https://www.ncbi.nlm.nih.gov/pubmed/33590606 http://dx.doi.org/10.1111/liv.14831 |
Ejemplares similares
-
Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2019) -
The quest for genetic risk factors for Crohn's disease in the post-GWAS era
por: Fransen, Karin, et al.
Publicado: (2011) -
Calprotectin instability may lead to undertreatment in children with IBD
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2020) -
Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
por: Karmi, Naomi, et al.
Publicado: (2021) -
Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
por: Malinová, Vĕra, et al.
Publicado: (2020)